Dublin, Ohio (February 25, 2013) – On March 6th the Columbus Metropolitan Club at the Athletic Club of Columbus will host a lunch meeting where Biosortia Pharmaceuticals’ President & CEO Kurt Dieck along with founder Ross Youngs will share a look at the vast potential for a whole new world of biopharmaceutical drug discovery from aquatic consortia. They will also provide a glimpse of algae’s applications in other fields including plastics and energy. Ross O. Youngs is one of CMC’s favorite speakers, part scientist, part entrepreneur, and passionate about both.

Follow this link to learn more about the event. CMC Event Details

###

About Biosortia Pharmaceuticals – Biosortia Pharmaceuticals Biosortia Pharmaceuticals is a division of Algaeventure Systems (AVS). Biosortia has a proven and unique ability to obtain unculturable aquatic microorganism consortia from the natural environment in unprecedented quantities that allows its research team to perform a direct study of vast quantities of new natural products. Biosortia is actively engaging drug research and development organizations to explore the vast opportunity of unculturable microorganisms for potential therapeutic agents, and other novel compounds of value in biotechnology fields

Ross Youngs, Founder, and Chairman – Since 1980, Ross has been inventing technologies and products for a variety of industries. In 1988, he founded Univenture which focused on consumer products and industrial packaging. A number of companies have spun out of Univenture, including UniKeep LLC, BioBent Plastics, Algaeventure Systems, and Biosortia Pharmaceuticals. Univenture is a 5 time Inc 500 company and has numerous technical and market recognitions. Ross was named the Nation’s Business Person of the Year in 1998 by the SBA.

If you’d like more information about the announcement or the company or to schedule an interview with Kurt Dieck, please call David Coho at 614-325-9804 or e-mail David at dc***@*******ia.com